Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

NCT00038142 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

46

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Ewing's Sarcoma

Interventions

DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Dexrazoxane
BIOLOGICAL: ImmTher

Sponsor

M.D. Anderson Cancer Center